2026-09-23T05:28:57Zhttps://gupea.ub.gu.se/server/oai/request

oai:gupea.ub.gu.se:2077/367562014-11-04T02:34:05Zcom_2077_282com_2077_17com_2077_10556col_2077_544col_2077_310col_2077_10557

Skiljic, Dragana 2014-11-03T09:51:46Z 2014-11-03T09:51:46Z 2014-11-03 978-91-628-9187-9 http://hdl.handle.net/2077/36756 Cataract is an opacification of the eye lens, constituting the major cause of blindness globally. Oxidative stress is a key factor in the formation of cataract and female gender is a known risk factor for age-related cataract. The aim of this thesis was to investigate the role of estrogen and the antioxidant enzyme superoxide dismutase (SOD) in cataractogenesis. Human lens epithelial cells (HLECs) obtained during cataract surgery at the Department of Ophthalmology at Sahlgrenska university hospital in Mölndal (SU/M) were used to study the effects of the major estrogen, 17β-estradiol (E2), on proliferation, cell viability, intracellular redox status, SOD and estrogen receptors (ERs). H2O2-induced oxidative stress was used to study the antioxidative properties of E2 in HLECs. Two genetic association studies were performed to investigate if genetic variations in estrogen-related and in SOD genes were associated with increased risk of cataract in an Estonian population, consisting of 492 patients with age-related cataract and 185 controls. Patients and controls were also recruited from the Eye Clinic at SU/M for a study on possible correlations between E2 levels and SOD activity. The effects of E2 at pharmacological concentrations in HLECs were; increased apoptosis and cell death, reduced cell viability and proliferation as well as increased intracellular levels of reactive oxygen species (ROS). At lower (physiologic) concentrations, increased proliferation, reduced cell death, stabilization of mitochondrial membrane potential and protection against oxidative stress by reduction of ROS were observed. At these concentrations total SOD activity was increased and protein expression levels of ERs were altered. However, no change in neither gene nor protein expression levels of SODs was seen. A linear correlation between increasing age and declining E2 serum levels was evident in cataract patients and controls. Men exhibited higher E2 levels compared to postmenopausal women. However, no correlation between serum levels of E2 and SOD activity was found in our study subjects. The genetic association studies showed that genetic variations in SOD and estrogen-related genes were not associated with increased risk of cataract. In conclusion, no correlation between SOD activity and E2 serum levels in cataract patients and controls was found and genetic variations in SOD or estrogen-related genes showed no association with increased risk of cataract in our subjects. The observed increase in SOD activity after exposure to E2 and reduction of ROS after preincubation with E2 in oxidatively stressed cells, support a role for E2 in the protection against oxidative stress in HLECs. The antioxidative effect of E2 in lens epithelial cells appears to be induced by non-genomic mechanisms. eng I.Celojevic D et al. Effects of 17β-estradiol on proliferation, cell viability and intracellular redox status in native human lens epithelial cells. Molecular Vision. 2011; 17:1987-1996. ::PMID::21850173 II.Celojevic D et al. Superoxide dismutase gene polymorphisms in patients with age-related cataract. Ophthalmic Genetics. 2013; 34(3):140-145. ::PMID::23289810 III. Skiljic D et al. Estrogen–related polymorphisms in Estonian patients with age-related cataract. Submitted manuscript, 2014. IV. Skiljic D et al. Effects of 17β-estradiol on activity, gene and protein expression of superoxide dismutases in human lens epithelial cells. Manuscript. V. Skiljic D et al. Estradiol levels and superoxide dismutase activity in patients with age-related cataract. Manuscript. cataract estrogen gender antioixidant enzyme lens epithelial cells oxidative stress polymorphism superoxide dismutase The role of estrogen and superoxide dismutase in cataractogenesis text Doctoral thesis Doctor of Philosophy (Medicine) dragana.skiljic@gu.se University of Gothenburg. Sahlgrenska Academy Institute of Neuroscience and Physiology. Department of Clinical Neuroscience and Rehabilitation Fredagen den 21 november 2014, kl. 9.00, Hörsal Arvid Carlsson, Academicum, Medicinaregatan 3 2014-11-21 SA open.access